ACM
RGNX icon

Aquilo Capital Management’s Regenxbio RGNX Stock Holding History

Aquilo Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-271,302
Closed -$1.94M – 11
2025
Q1 		$1.94M Sell
271,302
-75,000
-22% -$558K 3.48% 8
2024
Q4 		$2.68M Sell
346,302
-584,406
-63% -$5.49M 4.04% 8
2024
Q3 		$9.76M Buy
930,708
+24,460
+3% +$298K 7.4% 5
2024
Q2 		$10.6M Hold
906,248
– – 10.22% 4
2024
Q1 		$19.1M Buy
906,248
+103,824
+13% +$1.85M 14.31% 2
2023
Q4 		$14.4M Sell
802,424
-45,000
-5% -$793K 8.98% 7
2023
Q3 		$13.9M Sell
847,424
-22,690
-3% -$411K 12.64% 3
2023
Q2 		$17.4M Buy
870,114
+39,100
+5% +$753K 9.64% 5
2023
Q1 		$15.7M Sell
831,014
-66,670
-7% -$1.48M 6.51% 7
2022
Q4 		$20.4M Sell
897,684
-70,000
-7% -$1.58M 7.65% 6
2022
Q3 		$25.6M Sell
967,684
-200,000
-17% -$5.93M 9.22% 6
2022
Q2 		$28.8M Buy
1,167,684
+49,000
+4% +$1.22M 9.84% 6
2022
Q1 		$37.1M Buy
1,118,684
+105,088
+10% +$2.92M 5.46% 7
2021
Q4 		$33.1M Buy
1,013,596
+174,457
+21% +$5.94M 3.76% 6
2021
Q3 		$35.2M Buy
839,139
+243,695
+41% +$8.77M 6.39% 6
2021
Q2 		$23.1M Buy
595,444
+36,000
+6% +$1.29M 6.01% 8
2021
Q1 		$19.1M Buy
559,444
+56,000
+11% +$2.39M 3.45% 11
2020
Q4 		$22.8M Sell
503,444
-7,316
-1% -$256K 4.75% 10
2020
Q3 		$14.1M Sell
510,760
-42,693
-8% -$1.39M 1.49% 10
2020
Q2 		$20.4M Buy
553,453
+280,242
+103% +$10.4M 4.11% 9
2020
Q1 		$8.85M Buy
273,211
+4,433
+2% +$185K 3.45% 12
2019
Q4 		$11M Buy
+268,778
New +$10.6M 4.14% 10

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Aquilo Capital Management's RGNX Position: Q2 2025 in Review

Aquilo Capital Management sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 271,302 shares — an estimated $1.94M sold.

Aquilo Capital Management first reported a position in RGNX in Q4 2019 and held it in 22 quarters. The position peaked at $37.1M in Q1 2022. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • Aquilo Capital Management reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
  • Aquilo Capital Management sold 271,302 Regenxbio shares in Q2 2025, an estimated $1.94M.
  • Aquilo Capital Management first reported a position in Regenxbio in Q4 2019 and held it in 22 quarters.
  • Aquilo Capital Management's Regenxbio position peaked at $37.1M in Q1 2022.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Aquilo Capital Management's 13F filing for Q2 2025.